Altair-1040-VERSA Laser with built in GDD precompensation and AOM-based power modulation
ID: 75N95025Q00011Type: Sources Sought
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIDABethesda, MD, 20892, USA

NAICS

Commercial and Service Industry Machinery Manufacturing (333310)

PSC

IMAGING EQUIPMENT AND SUPPLIES: MEDICAL, DENTAL, VETERINARY (6525)

Original Source

https://sam.gov/opp/61c8b04b9b5a4a70b7407fa0c96002b1/view
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract to Luminescent Consulting LLC for consulting services related to medical device development under the Blueprint MedTech Initiative. The primary objective of this procurement is to secure a subject matter expert with at least 20 years of experience in the medical device industry, including a minimum of 10 years in a Program Director role, to provide strategic guidance and technical support for various projects aimed at advancing neurological medical device technologies. This initiative is crucial for accelerating the translation of innovative neurotechnologies into clinical applications, ultimately enhancing patient access to effective medical devices. Interested parties may contact Tracy Cain at tracy.cain@nih.gov or Llakim Dubroff at llakim.dubroff@nih.gov for further information, although this is a presolicitation notice and not a competitive proposal request.

    Point(s) of Contact
    Frederick Weddington
    (301) 594-6835
    frederick.weddington@nih.gov
    Files
    Title
    Posted
    B. Sources Sought Notice - (75N95025Q00011).pdf
    The document is a Sources Sought Notice from SAM.gov for a federal procurement involving the Altair-1040-VERSA Laser, which incorporates built-in GDD precompensation and AOM-based power modulation. The notice seeks to determine the availability of qualified companies that can meet specific technical requirements and provide the laser equipment. Key requirements include specifications on wavelength, average power, pulse duration, energy per pulse, beam divergence, and stability parameters, among others. Interested companies must submit comprehensive capability statements addressing each requirement, including their business type, size, professional qualifications, and contact information. The document emphasizes that this notice is purely informational and does not obligate the government to award any contracts. Submissions are to be made electronically by October 28, 2024. This initiative reflects the government’s effort to gather information on potential suppliers capable of delivering high-quality optical instruments derived from U.S. sources for laboratory use, furthering advancements in laboratory analytical instruments.
    NOI SS Luminescent.pdf
    The National Institute on Drug Abuse (NIDA) issued a Notice of Intent to award a sole source contract to Luminescent Consulting LLC for consulting services under the Blueprint MedTech Initiative, which focuses on developing medical devices targeting neurological conditions. The chosen consultant must have extensive industry experience, including at least 20 years in medical device companies and 10 years in a program director role. The consultant will provide expertise and guidance to support various medical device research projects. This contracting decision is justified under the Federal Acquisition Regulation allowing for limited competition due to the specialization required. The Blueprint MedTech program, established in 2019 with significant funding, aims to accelerate the development and translation of novel neurotechnologies into clinical applications. It intends to enhance patient access to innovative medical devices through strategic support and resources, fostering industry collaboration that could lead to clinically viable solutions. Interested parties may respond to this notice, although it is not a competitive proposal request, and their responses will assist the government in deciding whether to pursue a non-competitive contract.
    Similar Opportunities
    Consulting Services in relation to Medical Device Development under Blueprint MedTech Initiative – Subject Matter Expert in Medical Device Investment
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole-source contract for consulting services related to medical device development under the Blueprint MedTech Initiative. The objective is to procure a subject matter expert with extensive experience in neurotechnology and mental health product development, who will provide technical guidance and strategic oversight as a member of the Blueprint MedTech External Oversight Committee. This initiative, established in 2019 with a budget of $32 million, aims to facilitate the transition of innovative neurotechnologies to clinical studies, addressing the challenges faced by innovators in the medical device sector. Interested parties may express their capabilities, but the decision to proceed with competition remains at the government's discretion. For inquiries, contact Tracy Cain at tracy.cain@nih.gov or Llakim Dubroff at llakim.dubroff@nih.gov, both reachable at 301-443-6677.
    Consulting Services in relation to Medical Device Development under Blueprint MedTech Initiative – Subject Matter Expert in Neurology
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute on Drug Abuse (NIDA), intends to award a sole source contract for consulting services related to medical device development under the Blueprint MedTech Initiative, focusing on the need for a subject matter expert in neurology. The contract aims to procure specialized consulting services from a board-certified neurologist with experience in treating neurological conditions and expertise in medical device regulation, who will provide strategic guidance and technical oversight to enhance medical device projects within the initiative. This procurement is critical as it supports the development of innovative medical devices aimed at addressing neurological disorders, facilitating the translation of novel technologies from early-stage development to clinical studies. Interested parties may express their interest and capability, but the decision to seek competitive proposals remains at the government's discretion, with all submissions due by November 4, 2024. For further inquiries, contact Tracy Cain at tracy.cain@nih.gov or Llakim Dubroff at llakim.dubroff@nih.gov.
    Consulting Services in relation to Medical Device Development under Blueprint MedTech Initiative – Subject Matter Expert in Medical Insurance
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract for consulting services related to medical device development under the Blueprint MedTech Initiative. The primary objective is to engage Dr. Rhonda Robinson Beale, a Woman Owned Small Business (WOSB), who possesses over 15 years of experience in U.S. medical insurance, including five years as a Chief Medical Officer, to provide expert guidance on medical device projects. This initiative is crucial for accelerating the development of innovative neurological medical devices, offering resources such as funding and expertise in regulatory and commercialization strategies to support early-stage development. Interested parties can reach out to Tracy Cain at tracy.cain@nih.gov or Llakim Dubroff at llakim.dubroff@nih.gov for further information, although the contract will not be open for full competition.
    Notice of Intent to Sole Source; 3M Health Information Systems
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract to 3M Health Information Systems for the acquisition of the 360 Encompass application. This procurement aims to replace the existing 3M Clinical Abstracting (ClinTrac) system, which is being phased out by the vendor, ensuring continuity in health information management services. The 360 Encompass application is critical for clinical documentation improvement, coding excellence, and computer-assisted coding, and it integrates seamlessly with the NIH's existing infrastructure, minimizing additional costs and implementation time associated with switching vendors. Interested parties may submit their capabilities and interest to Kristin Nagashima at kristin.nagashima@nih.gov by November 6, 2024, at 3 PM EST.
    Notice of Intent to Sole Source; Monument Medical
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract to Monument Medical Inc. for the procurement of amicus apheresis kits, which are essential for mononuclear cell collection at the NIH Clinical Center blood bank. This acquisition is critical due to the urgency of the requirement, as a delay could impact the availability of blood bags necessary for immediate patient care. The contract will be awarded under simplified acquisition procedures, with a total quantity of 240 kits required, and interested parties may submit their capabilities and interest to the NIH by November 1, 2024, at 10 AM EST, via email to Kristin Nagashima at kristin.nagashima@nih.gov.
    Notice of Intent to Sole Source; Harris OnPoint
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract to Harris OnPoint Solutions for the provision of technical services related to the AcuityPlus software at the NIH Clinical Center in Bethesda, Maryland. The acquisition aims to ensure annual maintenance and support for the AcuityPlus system, which is critical for enhancing productivity and identifying best practices by comparing acuity data across organizations. As Harris OnPoint is the sole manufacturer and licenser of the AcuityPlus system, no new training is required for the nursing staff already utilizing the software. Interested parties may express their interest and capabilities to Kristin Nagashima at kristin.nagashima@nih.gov by October 31, 2024, at 1 PM EST.
    Notice of Intent to Sole Source; Monument Medical
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract to QuVA Pharma, Inc. for the procurement of compounded intravenous (IV) narcotics for patient care at the NIH Clinical Center. This acquisition aims to secure sterile compounded products that meet the quality standards necessary for ongoing patient treatment, as QuVA Pharma is the sole distributor of these specific IV narcotics in the U.S. market. Interested parties are invited to express their interest and capabilities regarding this procurement, with comments due by November 15, 2024, at 10 AM EST, directed to Kristin Nagashima at kristin.nagashima@nih.gov.
    PMT Accessories and Electrodes for Department of Perioperative Medicine at the NIH Clinical Center
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) is seeking to procure PMT accessories and electrodes for the Department of Perioperative Medicine at the NIH Clinical Center in Bethesda, Maryland. The acquisition aims to purchase specialized electrodes and accessories from PMT Corporation, which are essential for ensuring maximum electrical conductivity in patients' brains during medical procedures, utilizing various wiring configurations. These products are critical for neurosurgery and electrophysiology applications, and PMT Corporation is the exclusive manufacturer of these items, with no alternative vendors available. Interested parties may submit their capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by October 30, 2024, at 6:30 AM EST, as this is not a request for proposals but a presolicitation notice.
    Maintenance Service for two (2) Illumina NextSeq™ 1000 Sequencers
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract to Illumina, Inc. for maintenance services on two Illumina NextSeq™ 1000 Sequencers. The contract will cover comprehensive support, including parts, labor, travel, and technical assistance, essential for high-throughput next-generation sequencing used in diagnosing inherited immune disorders. This acquisition is critical as Illumina is the sole manufacturer with the necessary components and expertise to maintain the equipment to its original specifications. Interested parties capable of providing similar services may submit a capability statement to Kimala Winfield at kimala.winfield@nih.gov or Malinda Dehner at dehnerm@cc.nih.gov, with submissions due by the specified deadline.
    Notice of Intent to Sole Source; Infor Software
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract to Infor (US), LLC for the maintenance software license, maintenance, and support of Infor / Lawson Applications at the NIH Clinical Center in Bethesda, Maryland. This acquisition is crucial for ensuring the continued operation and support of various software modules utilized within the NIH, including financial management and inventory control systems, which are essential for the center's clinical and administrative functions. The contract will be awarded under the Federal Acquisition Regulation (FAR) Part 13, with a total value not exceeding $7.5 million, and interested parties may submit their capabilities and interest to the primary contact, Kristin Nagashima, via email by November 1, 2024, at 10 AM EST.